Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxamyl SCHEMBL26950 | 0.92 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL1765917 | 0.92 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL7871702 | 0.92 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL5802654 | 0.92 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL5695469 | 0.91 | TDP1 (0.37) | TDP1 | |
| Oxamyl SCHEMBL9276500 | 0.89 | TDP1 (0.36) | TDP1 | |
| Oxamyl SCHEMBL21327715 | 0.88 | TDP1 (0.35) | TDP1 | |
| Oxamyl SCHEMBL2239191 | 0.88 | TDP1 (0.35) | TDP1 | |
| Oxamyl SCHEMBL28442757 | 0.86 | TDP1 (0.34) | TDP1 | |
| Oxamyl SCHEMBL28371792 | 0.86 | TDP1 (0.34) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1560820-B1 | NOVEL ANTHRANILAMIDE INSECTICIDES | DU PONT (US) | 2010-05-26 | — | — | EP | claimed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-7179824-B2 | E.g., N-(3-chloro-2-pyridinyl)-N-[2-methyl-6-[[(1-methylethyl)amino]carbonyl]phenyl]-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide; control of foliar- and soil-inhabiting arthropods and protection of agronomic and/or nonagronomic crops; veterinary medicine;environmentally friendly | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-20 | — | — | US | disclosed |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-04-07 | — | — | US | disclosed |
| US-20040186141-A1 | Arthropodicidal anthranilamides | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-09-23 | — | — | US | disclosed |
| US-4032654-A | Water-soluble, liquid concentrates of S-methyl-[(methyl-carbamoyl)oxy]-thioacetimidate and methyl N', N'-dimethyl-N-[(methyl-carbamoyl)oxy]-1-thiooxamimidate | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | ANTXR2, NIT2, TDO2 | TDP1 3701/4885 |
| US-20040186141-A1 | Arthropodicidal anthranilamides | ANTXR2, NIT2, NQO2 | TDP1 3793/4885 |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | ANTXR2, HRH4, HDAC10 | TDP1 3374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.